Prostaglandin E2 Regulates the Complement Inhibitor CD55/Decay-accelerating Factor in Colorectal Cancer
Open Access
- 1 January 2005
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 280 (1), 476-483
- https://doi.org/10.1074/jbc.m407403200
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Prostaglandin E2 Regulates Cell Migration via the Intracellular Activation of the Epidermal Growth Factor ReceptorJournal of Biological Chemistry, 2003
- Cyclooxygenase-2 and Colorectal CancerPublished by S. Karger AG ,2003
- Important Role of Phosphodiesterase 3B for the Stimulatory Action of cAMP on Pancreatic β-Cell Exocytosis and Release of InsulinJournal of Biological Chemistry, 2002
- C1-inhibitor: an anti-inflammatory reagent with therapeutic potentialExpert Opinion on Pharmacotherapy, 2001
- The complement regulatory proteins CD46 and CD59, but not CD55, are highly expressed by glandular epithelium of human breast and colorectal tumour tissuesAPMIS, 1998
- The host—tumor immune conflict: from immunosuppression to resistance and destructionImmunology Today, 1997
- Tumour necrosis factor‐α up‐regulates decay‐accelerating factor gene expression in human intestinal epithelial cellsImmunology, 1997
- Regulation of B-Cell Tolerance and Triggering by Macrophages and Lymphoid Dendritic CellsImmunological Reviews, 1990
- Enhanced glomerular prostaglandin formation in experimental membranous nephropathyKidney International, 1987